US Stock MarketDetailed Quotes

TMDX TransMedics

Watchlist
  • 76.320
  • +4.200+5.82%
Close Feb 28 16:00 ET
  • 76.100
  • -0.220-0.29%
Post 20:01 ET
2.57BMarket Cap75.56P/E (TTM)

About TransMedics Company

TransMedics Group, Inc. operates as a commercial stage medical technology company. The firm engages in the development and commercialization of organ care system platform. It focuses on the preservation of human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation. The company was founded by Waleed H. Hassanein in August 1998 and is headquartered in Andover, MA.

Company Profile

SymbolTMDX
Company NameTransMedics
Listing DateMay 2, 2019
Issue Price16.00
Founded1998
CEODr. Waleed Hassanein, M.D.
MarketNASDAQ
Employees584
Fiscal Year Ends12-31
Address200 Minuteman Road,Suite 302
CityAndover
ProvinceMassachusetts
CountryUnited States of America
Zip Code01810
Phone1-978-552-0900

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Waleed Hassanein, M.D.
  • President, Chief Executive Officer and Director
  • 6.76M
  • Gerardo Hernandez
  • Chief Financial Officer and Treasurer
  • --
  • Dr. Tamer Khayal, M.D.
  • Chief Commercial Officer
  • 2.63M
  • Anil P. Ranganath
  • Senior Vice President, General Counsel and Corporate Secretary
  • 2.19M
  • Nick Corcoran
  • Senior Vice President, Supply Chain and Operations
  • 2.52M
  • James R. Tobin
  • Chairman of the Board
  • 262.32K
  • Stephanie Lovell
  • Independent Director
  • 219.79K
  • Dr. David Weill, M.D.
  • Independent Director
  • 222.78K
  • Thomas J. Gunderson
  • Independent Director
  • 237.74K
  • Edward M. Basile
  • Independent Director
  • 232.26K
  • Edwin M. Kania, Jr.
  • Independent Director
  • 220.28K
  • Merilee Raines
  • Independent Director
  • 238.62K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
Unlock Now
Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio? Show More